Neuropsychopharmacology
- Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia2 years ago
- Replicability and generalizability in population psychiatric neuroimaging2 years ago
- What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?2 years ago
- Acute sleep disruption reduces fear memories in male and female mice2 years ago
- Prevalence and correlates of irritability among U.S. adults2 years ago
- Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants2 years ago
- Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers2 years ago
Journal of Psychopharmacology
- Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers4 years ago
- Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder4 years ago
- Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study4 years ago
- Body mass index (BMI) does not predict responses to psilocybin4 years ago
- Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice4 years ago
- Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis4 years ago
- Belief changes associated with psychedelic use4 years ago
European Neuropsychopharmacology
- Silexan for treatment of anxiety and depression in the context of COVID-193 years ago
- Defining cannabis risky use: Building the plane while you fly it3 years ago
- Robotics in psychiatry – Fiction or reality?3 years ago
- Premise, promise and challenges of MDMA assisted therapy for PTSD3 years ago
- Improving drug development in precision psychiatry by ameliorating cognitive biases3 years ago
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?3 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence3 years ago